BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
549 results:

  • 1. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
    Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The combination of il-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.
    Wang D; Wang X; Zhang Y; Yu L; An J; Wang X; Huang Y; Han X
    Front Immunol; 2024; 15():1309509. PubMed ID: 38352877
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
    Amaria R; Knisely A; Vining D; Kopetz S; Overman MJ; Javle M; Antonoff MB; Tzeng CD; Wolff RA; Pant S; Lito K; Rangel K; Fellman B; Yuan Y; Lu KH; Sakellariou-Thompson D; Haymaker CL; Forget MA; Hwu P; Bernatchez C; Jazaeri AA
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309721
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic association of circulating interleukins and risk of colorectal cancer: A bidirectional Mendelian randomization study.
    Dong J; Jiang W; Zhang W; Hu R; Huang Z; Guo T; Du T; Jiang X
    Environ Toxicol; 2024 May; 39(5):2706-2716. PubMed ID: 38240193
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases.
    Li CMY; Tomita Y; Dhakal B; Tin T; Li R; Wright JA; Vrbanac L; Woods SL; Drew P; Price T; Smith E; Maddern GJ; Fenix K
    Cancer Immunol Immunother; 2024 Jan; 73(1):6. PubMed ID: 38231291
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer.
    Toffoli EC; van Vliet AA; Verheul HWM; van der Vliet HJ; Tuynman J; Spanholtz J; de Gruijl TD
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056896
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models.
    Mahdi HS; Woodall-Jappe M; Singh P; Czuczman MS
    Front Immunol; 2023; 14():1268979. PubMed ID: 38022532
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cholesterol induction in CD8
    Shuwen H; Yinhang W; Jing Z; Qiang Y; Yizhen J; Quan Q; Yin J; Jiang L; Xi Y
    Cancer Immunol Immunother; 2023 Dec; 72(12):4441-4456. PubMed ID: 37919522
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Reigniting hope in cancer treatment: the promise and pitfalls of il-2 and il-2R targeting strategies.
    Muhammad S; Fan T; Hai Y; Gao Y; He J
    Mol Cancer; 2023 Jul; 22(1):121. PubMed ID: 37516849
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin.
    Ohana J; Sandler U; Devary O; Devary Y
    Oncotarget; 2023 Jul; 14():688-699. PubMed ID: 37395796
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
    Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
    Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Components and effectiveness of patient navigation programmes to increase participation to breast, cervical and colorectal cancer screening: A systematic review.
    Mosquera I; Todd A; Balaj M; Zhang L; Benitez Majano S; Mensah K; Eikemo TA; Basu P; Carvalho AL
    Cancer Med; 2023 Jul; 12(13):14584-14611. PubMed ID: 37245225
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exosomes-delivered PD-L1 siRNA and CTLA-4 siRNA protect against growth and tumor immune escape in colorectal cancer.
    Li J; Chen Y; Liao M; Yu S; Yuan B; Jia Z; Zhou L; Tang Y
    Genomics; 2023 Jul; 115(4):110646. PubMed ID: 37217085
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cytokine concentration in peripheral blood of patients with colorectal cancer.
    Li W; Chen F; Gao H; Xu Z; Zhou Y; Wang S; Lv Z; Zhang Y; Xu Z; Huo J; Zhao J; Zong Y; Feng W; Shen X; Wu Z; Lu A
    Front Immunol; 2023; 14():1175513. PubMed ID: 37063892
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association between oxidative stress, mitochondrial function of peripheral blood mononuclear cells and gastrointestinal cancers.
    Liu W; Gao Y; Li H; Wang X; Jin M; Shen Z; Yang D; Zhang X; Wei Z; Chen Z; Li J
    J Transl Med; 2023 Feb; 21(1):107. PubMed ID: 36765353
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Generation and Functional Characterization of PLAP CAR-T Cells against Cervical cancer Cells.
    Yekehfallah V; Pahlavanneshan S; Sayadmanesh A; Momtahan Z; Ma B; Basiri M
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139135
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
    Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB
    Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Correlation between IFNAR1 expression in peripheral blood T lymphocytes and inflammatory cytokines, tumor-infiltrating lymphocytes, and chemosensitivity in patients with colorectal cancer.
    Yang L; Zhang X; Huang X; Dong X; Jing S; Zhang Y; Zhao B; Wang Z; Qu H
    Cytokine; 2022 Nov; 159():156008. PubMed ID: 36063748
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Advances in delivery methods of
    ElFar OA; Billa N; Lim HR; Chew KW; Cheah WY; Munawaroh HSH; Balakrishnan D; Show PL
    Bioengineered; 2022 Jun; 13(6):14681-14718. PubMed ID: 35946342
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for colorectal cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.